While it has been suggested that ApoB and ApoA-I may play a more influential role in CVD prevention than total LDL and HDL, further research is needed to understand the optimal indicators of effective lipid-lowering treatment in patients at risk for stroke. Here, APOB is linked to stroke disorder.